Invitation to Autoliv's Q4, 2024 Earnings Call

2025-01-09 IDOPRESS

STOCKHOLM,Jan. 8,2025 -- Autoliv Inc.,plans to publish its Financial Report for the fourth quarter 2024 on Friday,January 31,2025 at 12:00 Central European Time (CET).

The report will be available atwww.autoliv.com.

In addition,a teleconference will take place the same day.

Q4 2024 Earnings Call:

Date:

January 31,2025


Time:

14:00 – 15:00 CET


Main speaker:

Mikael Bratt,President & CEO


To attend by webcast,please use the link on our web or the link below:


https://edge.media-server.com/mmc/p/a7ye6jc5

To attend by phone,use the link below to register your participation and obtain your personal pin code and phone number:


https://register.vevent.com/register/BI03e6c672dcf6461b81614a1148ffef82

Audio replay will be available after the conference until January 31,2026:


www.autoliv.com/investors/reports-presentations-transcripts

Transcript will be available on www.autoliv.com/investors/reports-presentations-transcripts

For more information about Autoliv,please visit www.autoliv.com

Best regards,


Anders Trapp


V.P. Investor Relations


Email: anders.trapp@autoliv.com


Phone: +46 (0)8 587 206 71

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/autoliv/r/invitation-to-autoliv-s-q4--2024-earnings-call,c4088883

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map